Standout Papers

Current Concepts in Mild Cognitive Impairment 1997 2026 2006 2016 3.7k
  1. Current Concepts in Mild Cognitive Impairment (2001)
    Ronald C. Petersen, Rachelle S. Doody et al. Archives of Neurology
  2. A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease (1997)
    Mary Sano, Christopher Ernesto et al. New England Journal of Medicine
  3. Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women (2003)
    Sally A. Shumaker, Claudine Legault et al. JAMA
  4. Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment (2005)
    Ronald Petersen, Ronald G. Thomas et al. New England Journal of Medicine
  5. Epidermal Growth Factor and Fibroblast Growth Factor-2 Have Different Effects on Neural Progenitors in the Adult Rat Brain (1997)
    H. Georg Kuhn, Jürgen Winkler et al. Journal of Neuroscience
  6. The Alzheimer's Disease Neuroimaging Initiative (2005)
    Susanne G. Mueller, Michael W. Weiner et al. Neuroimaging Clinics of North America
  7. Ways toward an early diagnosis in Alzheimer's disease: The Alzheimer's Disease Neuroimaging Initiative (ADNI) (2005)
    Susanne G. Mueller, Michael W. Weiner et al. Alzheimer s & Dementia
  8. A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease (2005)
    Mark H. Tuszynski, Leon J. Thal et al. Nature Medicine
  9. Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. (2003)
    Paul Aisen, Kimberly Schafer et al. PubMed
  10. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. (2000)
    Ruth A. Mulnard, Carl W. Cotman et al. PubMed
  11. Proliferation and Differentiation of Progenitor Cells Throughout the Intact Adult Rat Spinal Cord (2000)
    Philip J. Horner, Ann E. Power et al. Journal of Neuroscience

Immediate Impact

5 by Nobel laureates 19 from Science/Nature 129 standout
Sub-graph 1 of 17

Citing Papers

Lecanemab in Early Alzheimer’s Disease
2022 Standout
Donanemab in Early Alzheimer’s Disease
2021 Standout

Works of Leon J. Thal being referenced

Development of Cognitive Instruments for Use in Clinical Trials of Antidementia Drugs
1997

Author Peers

Author Last Decade Papers Cites
Leon J. Thal 8706 8601 4055 4462 203 24.8k
Steven E. Arnold 7659 9870 4517 4519 336 27.3k
Mony J. de Leon 11476 13296 3328 5986 297 30.0k
Anne M. Fagan 9167 14760 3827 5060 286 25.4k
Kenneth L. Davis 7316 3827 4196 4704 281 20.2k
Murray A. Raskind 5033 6577 3240 2837 275 22.1k
Claudia H. Kawas 14872 13353 2239 5583 235 31.3k
Barbara J. Crain 4792 7921 3616 2151 151 19.4k
Peter Paul De Deyn 4767 6325 3508 4151 615 23.8k
Elaine R. Peskind 5502 7742 2569 2633 293 22.4k
John H. Growdon 6067 12009 4410 4865 235 23.6k

All Works

Loading papers...

Rankless by CCL
2026